Related Experiment Video
Updated: Dec 6, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Challenges and future directions of potential natural products leads against 2019-nCoV outbreak
Meirambek Ospanov1,2, Francisco León3, Janar Jenis2
1National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38677, USA.
Abstract:
Except for Remdesivir® no other drug or vaccine has yet been approved to treat the coronavirus disease (COVID-19) caused by the virus known as, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Remdesivir® an small molecule and nucleic acid analogue, it is used to treat adults and children with laboratory confirmed COVID-19, only administrated in hospital settings. Small molecules and particularly natural products count for almost fifty percent of the commercially available drugs, several of them are marketed antiviral agents and those can be a potential agent to treat COVID-19 infections. This short review rationalized different key natural products with known activity against coronaviruses as potential leads against COVID-19.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
04:52Author Spotlight: Discovering New Biopesticides from Bioactive Soil Microbe-Derived Natural Products
Published on: July 26, 2024
Related Concept Videos
Drug Discovery: Overview
Microorganisms in Medicine and Therapeutics
Antimicrobial Effectiveness
Steps in Outbreak Investigation